Currently there are no guidelines recommending that testosterone replacement therapy be used for the treatment of amyotrophic lateral sclerosis. However, a recent study has shown that it may be a helpful therapy for those suffering from the condition.
ALS guidelines did not recommend testosterone for the treatment of amyotrophic lateral sclerosis
ALS or amyotrophic lateral sclerosis is a disease that causes a degeneration of the motor neurons in the brain and spinal cord leading to symptoms such as muscle weakness, numbness, and at times, cognitive dysfunction. https://regenics.com/testosterone-replacement-therapy/ with the disease have an expected life span of 10 years or so. This statistic is bolstered by the fact that males are more likely to contract the disease than females. The good news is that a small percentage of ALS sufferers may survive for a decade or more. In the absence of a cure, there are several treatment options.
The best place to start is with an experienced neurologist. A clinical evaluation is necessary to rule out conditions such as Alzheimer’s disease and other forms of dementia. Once the slew of tests are completed, the patient should be referred to a specialist for a proper diagnosis. The first step in the ALS triage process is to perform a full clinical and paraclinical examination. This may require repeating the same tests to determine the true diagnosis. A detailed examination of the patient’s vitals, medications, and other health-related data will reveal any pre-existing conditions and medications that may be contributing to the patient’s condition.
Although ALS does not have a cure, the right combination of treatment and medications may be able to slow down or reverse the disease. The best time to start is during the early stages of the disease when the majority of patients are unaware of their condition.
Gender-affirming hormone and surgical interventions on mental health
Despite an increasing number of states seeking to prohibit gender-affirming medical care for youth, the majority of these laws have not been passed into law. Instead, they have been challenged in court, temporarily blocking enforcement of their bans.
Several medical associations have recognized the medical necessity of gender affirming care for youth. These associations are concerned about the harmful effects of denying youth access to such services. These associations have expressed support for gender-affirming care as a means of validating gender identity, improving psychological well-being, and reducing short- and long-term adverse mental health outcomes.
Gender-affirming hormone and surgical interventions on mental health have been linked to improved psychological functioning and reduced depression. They have also been associated with decreased suicide risk and decreased suicidal ideation. Similarly, the presence of a parent supportive of gender identity has been associated with lower odds of suicidality.
While the health benefits of gender-affirming care are still being investigated, evidence suggests that such care may improve mental health among TGNB youths. Moreover, studies have also suggested that medical interventions may mitigate the risks of suicidality.
Although most studies evaluated participants with gender-affirming surgeries, some studies also evaluated participants without them. These studies included participants from Germany, Switzerland, the Netherlands, Turkey, Belgium, and France.
Gender-affirming hormone therapy involves the use of feminizing hormones, such as testosterone and anti-androgens. Regenics – peptides of therapy has been associated with improved psychological functioning, reductions in depression, and improvements in body satisfaction.
Symptoms of ALS
ALS (Amyotrophic Lateral Sclerosis) is a neurodegenerative disease. It affects the nerve cells in the brain and spinal cord. These nerve cells control voluntary muscle movement. As the disease progresses, motor neurons die and stop sending messages to muscles. This leads to progressive muscle weakness and paralysis. It’s a fatal disease.
People with ALS are diagnosed when their motor neurons begin to die and the muscles they control begin to fail. The symptoms can vary from person to person. They can include muscle weakness, muscle cramps, speech problems, and breathing problems.
People with ALS also develop problems with decision making and memory. They may also develop dehydration or malnutrition. In the advanced stages, breathing becomes difficult and patients have difficulty swallowing. They may require a breathing tube or tracheostomy, a surgical hole in the front of the neck leading to the trachea. They may also develop pneumonia. ALS is a fatal disease.
People with ALS typically start with progressive muscle weakness. ALS can start in the hands, feet, or muscles that control speech. The initial symptoms are usually mild and may not lead to a definitive diagnosis. They can be a sign of another illness, such as peripheral neuropathy.
Some people with ALS can develop pneumonia. If they are able to survive, they usually live for two to five years after their diagnosis. However, some patients live for 10 years or more.
18133 Ventura Blvd Suite C, Tarzana, CA 91356